{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:35:03Z","timestamp":1790753703318,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00198-023-06800-z","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T05:02:40Z","timestamp":1684904560000},"page":"1591-1600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study"],"prefix":"10.1007","volume":"34","author":[{"given":"Hyemi","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Joon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jung","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1082-7592","authenticated-orcid":false,"given":"Won-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"6800_CR1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0991","author":"C Eller-Vainicher","year":"2019","unstructured":"Eller-Vainicher C, Falchetti A, Gennari L, Cairoli E, Bertoldo F, Vescini F, Scillitani A, Chiodini I (2019) DIAGNOSIS OF ENDOCRINE DISEASE: evaluation of bone fragility in endocrine disorders. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-18-0991","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"6800_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tem.2020.01.011","volume":"31","author":"A Giustina","year":"2020","unstructured":"Giustina A (2020) Acromegaly and vertebral fractures: facts and questions. Trends Endocrinol Metab 31(4):274\u2013275. https:\/\/doi.org\/10.1016\/j.tem.2020.01.011","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"6800_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s42000-021-00275-5","volume":"20","author":"F Carrone","year":"2021","unstructured":"Carrone F, Ariano S, Piccini S, Milani D, Mirani M, Balzarini L, Lania AG, Mazziotti G (2021) Update on vertebral fractures in pituitary diseases: from research to clinical practice. Hormones (Athens) 20(3):423\u2013437. https:\/\/doi.org\/10.1007\/s42000-021-00275-5","journal-title":"Hormones (Athens)"},{"issue":"15","key":"6800_CR4","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/eurheartj\/ehab822","volume":"43","author":"S Hong","year":"2022","unstructured":"Hong S, Kim KS, Han K, Park CY (2022) Acromegaly and cardiovascular outcomes: a cohort study. Eur Heart J 43(15):1491\u20131499. https:\/\/doi.org\/10.1093\/eurheartj\/ehab822","journal-title":"Eur Heart J"},{"issue":"2","key":"6800_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1210\/jc.2014-2937","volume":"100","author":"G Mazziotti","year":"2015","unstructured":"Mazziotti G, Biagioli E, Maffezzoni F, Spinello M, Serra V, Maroldi R, Floriani I, Giustina A (2015) Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J Clin Endocrinol Metab 100(2):384\u2013394. https:\/\/doi.org\/10.1210\/jc.2014-2937","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6800_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","volume":"24","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Biller BMK, Freda PU et al (2021) A Pituitary Society update to acromegaly management guidelines. Pituitary 24(1):1\u201313. https:\/\/doi.org\/10.1007\/s11102-020-01091-7","journal-title":"Pituitary"},{"key":"6800_CR7","doi-asserted-by":"publisher","unstructured":"Giustina A, Barkan A, Beckers A et al (2020) A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab 105(4). https:\/\/doi.org\/10.1210\/clinem\/dgz096","DOI":"10.1210\/clinem\/dgz096"},{"issue":"2","key":"6800_CR8","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/EJE-19-0184","volume":"181","author":"G Mazziotti","year":"2019","unstructured":"Mazziotti G, Lania AGA, Canalis E (2019) MANAGEMENT OF ENDOCRINE DISEASE: Bone disorders associated with acromegaly: mechanisms and treatment. Eur J Endocrinol 181(2):R45\u2013R56. https:\/\/doi.org\/10.1530\/EJE-19-0184","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"6800_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/MED.0000000000000109","volume":"21","author":"JR Anthony","year":"2014","unstructured":"Anthony JR, Ioachimescu AG (2014) Acromegaly and bone disease. Curr Opin Endocrinol Diabetes Obes 21(6):476\u2013482. https:\/\/doi.org\/10.1097\/MED.0000000000000109","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"6","key":"6800_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00198-020-05769-3","volume":"32","author":"O Tran","year":"2021","unstructured":"Tran O, Silverman S, Xu X, Bonafede M, Fox K, McDermott M, Gandra S (2021) Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women. Osteoporos Int 32(6):1195\u20131205. https:\/\/doi.org\/10.1007\/s00198-020-05769-3","journal-title":"Osteoporos Int"},{"issue":"3","key":"6800_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s12020-021-02751-9","volume":"73","author":"MM Uygur","year":"2021","unstructured":"Uygur MM, Yazici DD, Bugdayci O, Yavuz DG (2021) Prevalence of vertebral fractures and serum sclerostin levels in acromegaly. Endocrine 73(3):667\u2013673. https:\/\/doi.org\/10.1007\/s12020-021-02751-9","journal-title":"Endocrine"},{"issue":"7","key":"6800_CR12","doi-asserted-by":"publisher","first-page":"e2843","DOI":"10.1210\/clinem\/dgac183","volume":"107","author":"S Frara","year":"2022","unstructured":"Frara S, Melin Uygur M, di Filippo L, Doga M, Losa M, Santoro S, Mortini P, Giustina A (2022) High prevalence of vertebral fractures associated with preoperative GH levels in patients with recent diagnosis of acromegaly. J Clin Endocrinol Metab 107(7):e2843\u2013e2850. https:\/\/doi.org\/10.1210\/clinem\/dgac183","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"6800_CR13","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1210\/jc.2013-1460","volume":"98","author":"G Mazziotti","year":"2013","unstructured":"Mazziotti G, Bianchi A, Porcelli T, Mormando M, Maffezzoni F, Cristiano A, Giampietro A, De Marinis L, Giustina A (2013) Vertebral fractures in patients with acromegaly: a 3-year prospective study. J Clin Endocrinol Metab 98(8):3402\u20133410. https:\/\/doi.org\/10.1210\/jc.2013-1460","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6800_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1530\/EJE-10-1005","volume":"164","author":"MJ Wassenaar","year":"2011","unstructured":"Wassenaar MJ, Biermasz NR, Hamdy NA et al (2011) High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur J Endocrinol 164(4):475\u2013483. https:\/\/doi.org\/10.1530\/EJE-10-1005","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"6800_CR15","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1210\/jc.2008-0791","volume":"93","author":"G Mazziotti","year":"2008","unstructured":"Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, Pontecorvi A, De Marinis L, Giustina A (2008) Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab 93(12):4649\u20134655. https:\/\/doi.org\/10.1210\/jc.2008-0791","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"6800_CR16","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s00198-021-06032-z","volume":"32","author":"J Ha","year":"2021","unstructured":"Ha J, Jeong C, Han KD, Lim Y, Kim MK, Kwon HS, Song KH, Kang MI, Baek KH (2021) Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data. Osteoporos Int 32(12):2543\u20132553. https:\/\/doi.org\/10.1007\/s00198-021-06032-z","journal-title":"Osteoporos Int"},{"key":"6800_CR17","doi-asserted-by":"publisher","unstructured":"Bolanowski M, Halupczok J, Jawiarczyk-Przybylowska A (2015) Pituitary disorders and osteoporosis. Int J Endocrinol 2015(206853. https:\/\/doi.org\/10.1155\/2015\/206853","DOI":"10.1155\/2015\/206853"},{"issue":"10","key":"6800_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/ERC-17-0253","volume":"24","author":"P Petrossians","year":"2017","unstructured":"Petrossians P, Daly AF, Natchev E et al (2017) Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) database. Endocr Relat Cancer 24(10):505\u2013518. https:\/\/doi.org\/10.1530\/ERC-17-0253","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"6800_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3803\/EnM.2018.33.2.260","volume":"33","author":"H Kwon","year":"2018","unstructured":"Kwon H, Jung JH, Han KD, Park YG, Cho JH, Lee DY, Han JM, Park SE, Rhee EJ, Lee WY (2018) Prevalence and annual incidence of thyroid disease in Korea from 2006 to 2015: a nationwide population-based cohort study. Endocrinol Metab (Seoul) 33(2):260\u2013267. https:\/\/doi.org\/10.3803\/EnM.2018.33.2.260","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"10","key":"6800_CR20","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.30773\/pi.2020.0143","volume":"17","author":"SM Wang","year":"2020","unstructured":"Wang SM, Han KD, Kim NY, Um YH, Kang DW, Na HR, Lee CU, Lim HK (2020) Association of alcohol intake and fracture risk in elderly varied by affected bones: A nationwide longitudinal study. Psychiatry Investig 17(10):1013\u20131020. https:\/\/doi.org\/10.30773\/pi.2020.0143","journal-title":"Psychiatry Investig"},{"issue":"5","key":"6800_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1530\/eje.1.02285","volume":"155","author":"T Ueland","year":"2006","unstructured":"Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J (2006) Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients. Eur J Endocrinol 155(5):709\u2013715. https:\/\/doi.org\/10.1530\/eje.1.02285","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"6800_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00774-005-0649-9","volume":"24","author":"M Bolanowski","year":"2006","unstructured":"Bolanowski M, Daroszewski J, Medra\u015b M, Zadrozna-Sliwka B (2006) Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. J Bone Miner Metab 24(1):72\u201378. https:\/\/doi.org\/10.1007\/s00774-005-0649-9","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"6800_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.14744\/nci.2020.35467","volume":"9","author":"ME Piskinpasa","year":"2022","unstructured":"Piskinpasa ME, Piskinpasa H (2022) Bone biochemical markers in acromegaly: An association with disease activity and gonadal status. North Clin Istanb 9(1):74\u201381. https:\/\/doi.org\/10.14744\/nci.2020.35467","journal-title":"North Clin Istanb"},{"issue":"4","key":"6800_CR24","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1210\/jc.2012-4073","volume":"98","author":"M Madeira","year":"2013","unstructured":"Madeira M, Neto LV, de Paula Paranhos Neto F, Barbosa Lima IC, Carvalho de Mendonca LM, Gadelha MR, Fleiuss de Farias ML (2013) Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 98(4):1734\u20131741. https:\/\/doi.org\/10.1210\/jc.2012-4073","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"6800_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000489672","volume":"47","author":"SM Ott","year":"2018","unstructured":"Ott SM (2018) Cortical or trabecular bone: What\u2019s the difference? Am J Nephrol 47(6):373\u2013375. https:\/\/doi.org\/10.1159\/000489672","journal-title":"Am J Nephrol"},{"issue":"12","key":"6800_CR26","doi-asserted-by":"publisher","first-page":"e10240","DOI":"10.1002\/jbm4.10240","volume":"3","author":"K Godang","year":"2019","unstructured":"Godang K, Lekva T, Normann KR, Olarescu NC, \u00d8ystese KAB, Kolnes A, Ueland T, Bollerslev J, Heck A (2019) Hip structure analyses in acromegaly: decrease of cortical bone thickness after treatment: a longitudinal cohort study. JBMR Plus 3(12):e10240. https:\/\/doi.org\/10.1002\/jbm4.10240","journal-title":"JBMR Plus"},{"issue":"6","key":"6800_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41574-022-00649-8","volume":"18","author":"G Mazziotti","year":"2022","unstructured":"Mazziotti G, Lania AG, Canalis E (2022) Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis. Nat Rev Endocrinol 18(6):353\u2013365. https:\/\/doi.org\/10.1038\/s41574-022-00649-8","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"6800_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/jbmr.3573","volume":"34","author":"Z Liu","year":"2019","unstructured":"Liu Z, Solesio ME, Schaffler MB, Frikha-Benayed D, Rosen CJ, Werner H, Kopchick JJ, Pavlov EV, Abramov AY, Yakar S (2019) Mitochondrial function is compromised in cortical bone osteocytes of long-lived growth hormone receptor null mice. J Bone Miner Res 34(1):106\u2013122. https:\/\/doi.org\/10.1002\/jbmr.3573","journal-title":"J Bone Miner Res"},{"issue":"1","key":"6800_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11102-017-0847-1","volume":"21","author":"L Dalle Carbonare","year":"2018","unstructured":"Dalle Carbonare L, Micheletti V, Cosaro E, Valenti MT, Mottes M, Francia G, Dav\u00ec MV (2018) Bone histomorphometry in acromegaly patients with fragility vertebral fractures. Pituitary 21(1):56\u201364. https:\/\/doi.org\/10.1007\/s11102-017-0847-1","journal-title":"Pituitary"},{"issue":"3","key":"6800_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/eje-16-0808","volume":"176","author":"F Malgo","year":"2017","unstructured":"Malgo F, Hamdy NAT, Rabelink TJ, Kroon HM, Claessen K, Pereira AM, Biermasz NR, Appelman-Dijkstra NM (2017) Bone material strength index as measured by impact microindentation is altered in patients with acromegaly. Eur J Endocrinol 176(3):339\u2013347. https:\/\/doi.org\/10.1530\/eje-16-0808","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"6800_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1159\/000511811","volume":"111","author":"M Cellini","year":"2021","unstructured":"Cellini M, Biamonte E, Mazza M et al (2021) Vertebral fractures associated with spinal sagittal imbalance and quality of life in acromegaly: a radiographic study with EOS 2D\/3D technology. Neuroendocrinology 111(8):775\u2013785. https:\/\/doi.org\/10.1159\/000511811","journal-title":"Neuroendocrinology"},{"issue":"2","key":"6800_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00198-003-1531-z","volume":"15","author":"P Vestergaard","year":"2004","unstructured":"Vestergaard P, Mosekilde L (2004) Fracture risk is decreased in acromegaly\u2013a potential beneficial effect of growth hormone. Osteoporos Int 15(2):155\u2013159. https:\/\/doi.org\/10.1007\/s00198-003-1531-z","journal-title":"Osteoporos Int"},{"issue":"2","key":"6800_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1530\/EJE-15-0931","volume":"174","author":"E Valassi","year":"2016","unstructured":"Valassi E, Crespo I, Malouf J, Llauger J, Aulinas A, Marin AM, Biagetti B, Webb SM (2016) Reduction of trabecular and cortical volumetric bone mineral density at the proximal femur in patients with acromegaly. Eur J Endocrinol 174(2):107\u2013114. https:\/\/doi.org\/10.1530\/EJE-15-0931","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"6800_CR34","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s12020-017-1238-0","volume":"55","author":"NM Appelman-Dijkstra","year":"2017","unstructured":"Appelman-Dijkstra NM, Biermasz NR (2017) Understanding and predicting fracture risk in acromegaly. Endocrine 55(3):662\u2013663. https:\/\/doi.org\/10.1007\/s12020-017-1238-0","journal-title":"Endocrine"},{"issue":"6","key":"6800_CR35","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s11102-022-01256-6","volume":"25","author":"C Ribeiro de Moura","year":"2022","unstructured":"Ribeiro de Moura C, Campos Lopes S, Monteiro AM (2022) Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis. Pituitary 25(6):780\u2013794. https:\/\/doi.org\/10.1007\/s11102-022-01256-6","journal-title":"Pituitary"},{"key":"6800_CR36","doi-asserted-by":"publisher","unstructured":"Sorohan MC, Poiana C (2022) Vertebral fractures in acromegaly: a systematic review. J Clin Med 12(1). https:\/\/doi.org\/10.3390\/jcm12010164","DOI":"10.3390\/jcm12010164"},{"key":"6800_CR37","doi-asserted-by":"publisher","unstructured":"Chiloiro S, Giampietro A, Frara S et al (2020) Effects of Pegvisomant and Pasireotide LAR on vertebral fractures in acromegaly resistant to first-generation SRLs. J Clin Endocrinol Metab 105(3). https:\/\/doi.org\/10.1210\/clinem\/dgz054","DOI":"10.1210\/clinem\/dgz054"},{"issue":"5","key":"6800_CR38","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s40618-022-01740-7","volume":"45","author":"E Vitali","year":"2022","unstructured":"Vitali E, Palagano E, Schiavone ML, Mantovani G, Sobacchi C, Mazziotti G, Lania A (2022) Direct effects of octreotide on osteoblast cell proliferation and function. J Endocrinol Invest 45(5):1045\u20131057. https:\/\/doi.org\/10.1007\/s40618-022-01740-7","journal-title":"J Endocrinol Invest"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06800-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06800-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06800-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T08:02:08Z","timestamp":1692086528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06800-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["6800"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06800-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"15 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hyemi Kwon, Kyung-Do Han, Bong-Sung Kim, Sun Joon Moon, Se Eun Park, Eun-Jung Rhee, and Won-Young Lee declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Hyemi Kwon, Kyung-Do Han, Bong-Sung Kim, Sun Joon Moon, Se Eun Park, Eun-Jung Rhee, and Won-Young Lee declare that they have nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosure"}}]}}